None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adults aged between 18 and 54 who have diagnosed with androgenetic alopecia 1-1) Adult patients diagnosed by Basic and specific (BASP) classification - basic type is a patient who is diagnosed with androgenetic alopecia with M1 or higher or C1 or higher or U1 or higher, - specific type is a patient who is diagnosed with androgenetic alopecia as V1 or higher or F1 or higher 1-2) Male patients diagnosed as 2 or 2A or higher by the Norwood-Hamilton classification 1-3) Female patients diagnosed as 1 or higher by the Ludwig classification 2.Subjects who will not have special hair care products or hair care and manipulation during the study period 3.Subjects who will maintain the same hair shape and color at the time of the first visit during the study period 4.Subjects who understand the purpose of this test and agrees in writing to the consent form
Exclusion criteria
Exclusion criteria: 1.Subjects who have severe acute kidney or heart disease or chronic diseases (hypertension, diabetes, etc.) that may affect the test results in the last 6 months 2.Females who are in the period of pregnant, breast-feeding or planning to be pregnant within 6 months 3.Subjects who have mental illness 4.Subjects who have infectious skin diseases 5.Subjects who have undergone surgical treatment for hair loss such as hair transplantation and scalp reduction 6.Subjects who have taken oral Dutasteride or Finasteride within the last 6 months 7.Subjects who have been applying topical hair growth, wool, and hair growth in the last 1 month 8.Subjects who are taking following medicines within 1 month: steroids, apoptotic drugs, vasodilator, antihypertensive drugs, anti-epileptics, beta-blockers, bronchodilator, diuretics, spironolactone, cimetidine, diazoxide, cyclosporine and ketoconazole 9.Subjects who have applied topical steroids to the scalp in the last 1 month 10.Subjects who are judged to have difficulty in applying test substances due to severe seborrheic dermatitis, scalp psoriasis, and scalp infection 11.Subjects who have other alopecia diseases such as alopecia areata, resting alopecia, and scarring alopecia, in addition to androgenetic alopecia 12.Subjects who are undernourished due to excessive dietary restrictions or stomach resection, or who take nutritional supplements that can affect hair loss 13.Any subjects who are considered to be inappropriate to participate in the study by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair density | — |
Secondary
| Measure | Time frame |
|---|---|
| ?Visual Evaluation of Hair Density by Experts | — |
Countries
Korea, Republic of
Contacts
P&K Skin Research Center